2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia Riboflavin, VEGA UV-A Illumination System - Keratoconus and Ectasia | Phase 3 | Terminated | Topcon Medical Systems, Inc. | 500 | 2010-12-01 | 2022-06-29 |
| Safety Study of the VEGA UV-A System to Treat Ectasia VEGA UV-A Illumination System, Riboflavin - Ectasia | Phase 3 | Terminated | Topcon Medical Systems, Inc. | 103 | 2010-12-01 | 2022-06-29 |
Keratoconus (1)
Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Corneal Diseases (1) · Eye Diseases (1)
Riboflavin (2)
Topcon Medical Systems, Inc. (2)
United States (2)